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Objectives. To investigate whether lifestyle-only intervention in obese children who maintain or lose a modest amount of weight
redistributes parameters of body composition and reverses metabolic abnormalities. Study Design. Clinical, anthropometric, and
metabolic parameters were assessedin 111 overweight or obese children (CA of 11.3 ± 2.8 years; 63 females and 48 males), during
8 monthsof lifestyle intervention.Patients maintainedor lost weight (1–5%) (group A; n: 72) or gained weight (group B). Results.
Group A patients presented with a decrease in systolic blood pressure (SBP) and diastolic blood pressure (DBP) (P<. 005 and
P<. 05, resp.), BMI (P<. 0001), z-score BMI (P<. 0001), waist circumference (P<. 0001), fat mass (P<. 005), LDL-C (P<. 05),
Tg/HDL-C ratio (P<. 05), fasting and postprandial insulin (P<. 005), and HOMA (P<. 005), while HDL-C (P<. 05) and
QUICKI increased (P<. 005). Conversely, group B patients had an increase in BMI (P<. 0001), waist circumference (P<. 005),
SBP (P<. 005), and in QUICKI (P<. 005), while fat mass (P<. 05), fasting insulin (P<. 05), and HOMA (P<. 05) decreased.
Lean mass,DBP, lipid concentrations,fasting and postprandial glucose, postprandial insulin,and ultrasensitive C-reactive protein
(CRP) remained stable. Conclusions. Obese children who maintain or lose a modest amount of weight following lifestyle-only
intervention tend to redistribute their body fat, decrease blood pressure and lipid levels, and to improve parameters of insulin
sensitivity.
1.Introduction
The United States population has experienced a twofold to
fourfold increase in the prevalence of obesity in the last two
decades[1,2],withahigherincidenceamongyoungAfrican-
Americans and Latinos [3]. Data obtained in a major city
in the Venezuelan Andes seem to indicate a similar trend
[4, 5]. Childhood obesity may lead to diabetes mellitus,
cardiovascular disease, and premature death in adulthood
[6]. Similarly, diseases such as dyslipidemias and type 2
diabetes are now being more frequently detected in both
children and adolescents. Obese children have exhibited
insulin resistance, elevated blood pressure, and increased
concentrations of serum lipids. Higher body weight has
been accompanied by an accumulation of visceral fat as
well as elevated levels of alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) with hepatic steatosis
[7–13]. Obese children have also been found to be in a
proinﬂammatory state, characterized by increased ultrasen-
sitive C-reactive protein (CRP) concentrations, changes in2 International Journal of Pediatric Endocrinology
endothelial function, and alterations in arterial structure
[14, 15].
The eﬀect of modest nonpharmacological lifestyle-only
intervention on auxological and metabolic parameters in
obese children has not been conclusively determined, but
several recent studies have demonstrated an improvement
in body composition, a decrease in hemostatic and inﬂam-
matory markers, and an improvement in markers of insulin
sensitivity following intervention [16–19]. It is not yet clear
whether weight loss is required for these parameters to
improve and to be sustained in time. In this study, we
hypothesized that lifestyle-only intervention in obese chil-
dren could lead to an improvement of both anthropometric
and metabolic markers, even if weight loss was discrete or if
weight remained stable.
2.Materialsand Methods
2.1. Subjects. One hundred and eleven overweight or obese
children (63 females and 48 males), with a mean chronolog-
ical age of 11.3 ± 2.8 years, participated in the study. Fifty-
three of the patients were prepubertal or in early puberty
(Tanner stage I-II), whereas the rest were in puberty (Tanner
stage III-IV). Patients originated from the Endocrinology,
Nutrition, Growth, and DevelopmentClinics of the Hospital
de Clinicas Caracas in Caracas, Venezuela and the Instituto
Aut´ onomo Hospital Universitario de Los Andes (IAHULA)
in M´ erida, Venezuela. Only overweight or obese children,
as determined by a BMI (kg/m2) above the 90th percentile
or a Z-score BMI above 1.5 were included. Children with
cardiac, endocrine, renal, and other chronic abnormalities
and those receiving therapy (statins, glucocorticoids, omega
3, metformin, etc.) that could aﬀect cardiovascular or
metabolic function were excluded from the study. Patients
with acute or chronic inﬂammatory disease that could aﬀect
inﬂammatory markers or those with physical impediments
that could aﬀect their exercise capacity were excluded from
the study. All of our patients completed both baseline and 8-
month auxological and laboratory evaluations, regardless of
whether they followed lifestyle change recommendations.
2.2. Procedures. Patients were measured using a Harpenden
stadiometer. Body mass index (BMI) was calculated, and
subjects were classiﬁed utilizing the Fundacredesa-INN-
USB’sgrowthcurvesforVenezuelanchildren[20].According
to these curves the subjects were considered overweight if
they had a BMI equal to or greater than the 90th percentile
or a BMI z-score of >1.5. They were considered obese if
their BMI was above the 97th percentile or if their BMI z-
score was >2. The skin fold of the triceps was measured
using a special caliper. Subsequently, measurements were
taken of the circumferences of the left arm, the waist, and
the hip using a measurement tape, as indicated by the
National Health and Nutrition Examination Survey, 2000
[21]. The fat and lean mass were then calculated using a
mathematical formula (FM = TrF(LAC)/2 − p(TrF)
2/4a n d
LM = (LAC − pTrF)
2/4p, where FM is fat mass, LM is lean
mass, TrFisthetricepsfoldmeasurement, LACistheleftarm
circumference, and p = 3,141) [20]. Blood pressure (BP)
was measured in all children.
A fasting blood sample was obtained to determine levels
of glucose, lipids, insulin, and CRP. Then, a glucose load
of 1.75 grams per kilogram of body weight (maximum of
75g) was administered orally to each patient. Two hours
later, another blood sample was taken to determine glucose
and insulin levels. Serum cortisol and thyroid function
tests were measured at baseline in all patients and had to
be normal to be included in the study. After the evalu-
ation of baseline auxological and biochemical parameters,
patients’weight,height, bloodpressure, waist circumference,
hip circumference, and arm circumference were measured
monthly. Eight months later, the blood tests were repeated.
Glucose, triglycerides (Tg), total cholesterol (TC), and high-
density lipoprotein cholesterol (HDL-C) were measured by
enzymatic methods with a Technicon autoanalyzer utilizing
chemicals from Boehringer Mannheim Diagnostics. Low-
density lipoprotein cholesterol (LDL-C) was calculatedusing
the Friedwald formula (LDL-C = TC − Tg/5 + HDL-C)
[22]. Insulin, cortisol, and thyroid function tests (TSH,
FT4, and total T4) were measured by chemiluminescence
utilizinganImmulite1000analyzerfromSiemensHealthcare
Diagnostics with interassay and intraassay coeﬃcients of
variation of 6.5% and 5.4%, 7.8% and 7.7%, 8.9% and
3.9%, 4.1% and 4.4%, and 6.7% and 6.7%, respectively.
Ultrasensitive C-reactive protein (CRP) levels were deter-
mined by an immunometric assay (high-sensitivity enzyme
immunoassay for the quantitative determination of C-
reactive protein concentrations, DRG International, Inc,
USA) with intraassay and interassay coeﬃcients of variation
of 7.5% and 4.1%. The insulin resistance index, HOMA-
IR, was calculated with the following formula: Insulinemia
(uU/mL) × glicemia (mmoL/L)/22.5. The insulin sensitivity
index, QUICKI (quantitative insulin-sensitivity index), was
calculated using the formula: 1/[(log insulin 0min) +
(log glicemia 0 min)] [23, 24]. This study was performed
with the approval of the hospital’s ethics committee, and
authorization to participate in the study was obtained from
parents and/or representatives.
2.3. Lifestyle Intervention Program. Patients and parents
received a written form with general recommendations
regarding nutrition and physical activity. Additionally, a
subgroup was given a form in which to register weekly hours
of physical activity, number of steps taken per day, and
hoursperweekspentinsedentaryactivities, suchaswatching
television or playing with a computer. In an initial meeting,
children were informed of the changes in physical activity,
behavior, and nutrition that were expected of them. Parents
were stimulated to actively and responsibly participate in the
program.
Lifestyle changes includedlimiting thedurationoftelevi-
sion and computer activities. Patients were also encouraged
to restrict their caloric intake by reducing the frequency
of snack consumption, by exchanging high-calorie snacks
for low-calorie, low-fat, low-carbohydrate snacks, and by
limiting the consumption of sugar-based carbonated drinksInternational Journal of Pediatric Endocrinology 3
and juices. A balanced diet (proteins, carbohydrates, and
fat) with a high content of ﬁber and increased consumption
of vegetables, grains, and fruits was recommended. Patients
werestimulatedtoparticipatein thesupervised sport activity
of their choosing or, alternatively, to exercise at home on a
treadmillorwalkwiththeirparentsoroldersiblings.Initially,
these activities would be performed three times weekly, but
if possible their frequency would be increased to once per
day. At the same time, the duration of the physical activity
would be gradually increased in accordance with the child’s
exercise capacity. A subgroup of 36 patients were asked to
determine the number of steps taken per day with the use
of a pedometer (Omron model HJ-112INT), a device in the
form ofa watch thatcalculatesthenumberofstepstakenand
the distance covered by the subject who carries it [25, 26].
We considered physical activity to be any regular sport, in
addition to dance, aerobics, ballet, brisk walks, jogging, and
school physical education. We quantiﬁed this activity in
hours per week. In order to calculate the number of steps
taken per day, the pedometer was used for 5 days. Then, the
total number of steps taken during that period was divided
by 5 to determine the average number of steps per day. This
method was used to calculate the number of steps taken per
day before initiating lifestyle-only intervention and once the
intervention period was complete.
2.4. Statistical Analysis. The continuous variables are pre-
sented as mean ± standard deviation, and the categorical
variables are shown in numbers and percentages. Initially the
analysis was completed in all participants before and after
intervention. Data was subsequently evaluated according
to gender and pubertal development. Subjects were ﬁnally
subdivided into 2 groups, one where they either maintained
their weight or experienced a modest weight loss of 1–
5% (group A; n:72, mean chronological age of 11.8 ± 2.7
years, 45 females and 27 males) and another where they
experienced a mean weight gain of 6.6% (group B; n:39,
mean chronological age of, 10.5 ± 2.7 years, 19 females and
20 males). The statistical diﬀerences of normally distributed
variables were analyzed according to gender and pubertal
statususingthenonpaired Student’st-test.Thestatistical dif-
ferences of nonnormally distributed variables were analyzed
according to gender and pubertal status using the Mann-
Whitney test (blood pressure, insulin, HOMA-IR,and CRP).
Furthermore, whereas the paired Student t-test was used
to analyze the statistical diﬀerences of normally distributed
variables before and after intervention, the Wilcoxon test
was employed to analyze those of nonnormally distributed
variables. A logistic regression analysis to determine the
inﬂuence of gender and pubertal development over the loss
or gain of weight of patients was also performed. A P<
.05 was considered signiﬁcant. The statistical package SPSS,
version 15, was utilized.
3.Results
3.1. Total Group. Children in our group as a whole had
a signiﬁcant decrease in BMI, z-score BMI, and fat mass
(P<. 0001) during the 8-month-long intervention period.
While QUICKIincreased (P<. 0001)following intervention,
LDL-C (P<. 005), Tg/HDL-C ratio (P<. 05), fasting
insulin concentrations (P<. 005), postprandial insulin
concentrations (P<. 005), and HOMA (P<. 0001)
decreased signiﬁcantly. HDL-C levels were low at baseline
and increased following intervention (P<. 05). Waist
circumference, waist/hip ratio, lean mass, SBP, DBP, fasting
glucose, postprandial glucose, and CRP were normal at
baseline and remained stable during the 8-month period.
Results of the total group can be seen in Table 1.
We also analyzed the data of the total population
according to gender (Table 2) and pubertal status (Table 3).
Changes noted during the intervention period were mostly
similar in males and females (both exhibited an increase
in QUICKI levels and a decrease in BMI, z-score BMI,
fat mass, fasting insulin, and HOMA. Neither showed
changes in waist circumference, waist/hip ratio, lean mass,
SBP, DBP, fasting glucose, postprandial glucose, TC, Tg,
and CRP concentrations during this period). However,
only females exhibited decreased postprandial insulin lev-
els, a lower Tg/HDL-C ratio, and signiﬁcant increases
in HDL-C. Conversely, LDL-C concentrations decreased
only in males (Table 2). Postprandial insulin levels, both
before and after life-style only intervention, and post-
prandial glucose and fasting insulin concentrations before
intervention were higher in females than in males. In
contrast the waist/hip ratio, both before and after inter-
vention, was increased in males (Table 2). Analysis of
our data by pubertal staging revealed a similar decrease
in BMI, z-score BMI, and fat mass and an increase
in QUICKI in both prepubertal and pubertal children.
No change in waist circumference, waist/hip ratio, lean
mass, SBP, DBP fasting glucose, Tg, TC, HDL-C, Tg/HDL
ratio, and CRP levels was noted in either group fol-
lowing intervention. Fasting insulin, postprandial insulin,
HOMA, and LDL-C levels decreased signiﬁcantly fol-
lowing intervention only in prepubertal children. Con-
versely, postprandial glucose levels decreased signiﬁcantly
only during puberty (Table 3). BMI, waist circumfer-
ence, fat mass, lean mass, SBP, fasting and postprandial
insulin, and HOMA were higher, and QUICKI was lower
both before and after intervention in pubertal subjects
(Table 3).
3.2. Group A. When we compared the variables before and
after intervention, patients who either maintained their
weight or had a modest weight loss presented with a
signiﬁcant decrease in SBP and DBP (P<. 005 and P<. 05),
in BMI, Z-score BMI, waist circumference (P<. 0001), and
fat mass (P<. 005) following intervention. LDL-C (P<. 05),
Tg/HDL ratio (P<. 05), fasting and postprandial insulin
(P<. 005), and HOMA (P<. 005) decreased signiﬁcantly
during the 8-month intervention period in these patients,
while HDL (P<. 05) and QUICKI increased (P<. 005).
Fasting and postprandial glucose concentrations and CRP
were normal at baseline and remained unchanged during the
intervention period (see Table 4).4 International Journal of Pediatric Endocrinology
Table 1: Laboratory and clinical variables before and after intervention of all obese children.
Variables Preintervention n = 111 Postinterventionn = 111
Height (cm) 148.14 ± 14.87 150.12 ± 14.06∗∗∗
BMI (kg/m2) 27.22 ± 4.02 26.55 ± 4.06∗∗∗
Z-score BMI 2.08 ± 0.34 1.90 ± 0.45∗∗∗
Waist (cm) 85.65 ± 10.14 84.85 ± 10.23
Waist/Hip Ratio 0.89 ± 0.06 0.89 ± 0.07
Fat Mass (mm2)a 2760.3 ± 1049.1 2301.63 ± 664.8∗∗∗
Lean Mass (mm2)a 3963.9 ± 1731.2 4171.0 ± 1229.2
SBP (mm Hg) 106.71 ± 12.52 106.61 ± 11.12
DBP (mm Hg) 70.59 ± 9.16 68.40 ± 8.29
Fasting Glucose (mg/dL) 82.33 ± 9.22 83.82 ± 9.22
2 Hr pl Glucose (mg/dL) 96.24 ± 17.89 94.05 ± 17.10
Fasting Insulin (mU/mL) 10.75 ± 8.49 8.19 ± 9.76∗∗
2 Hr pl Insulin (mU/mL) 55.49 ± 53.23 40.03 ± 42.36∗∗
HOMA 2.22 ± 1.80 1.63 ± 1.73∗∗∗
QUICKI 0.36 ± 0.05 0.38 ± 0.04∗∗∗
Tg (mg/dL) 119.74 ± 65.66 114.34 ± 54.85
TC (mg/dL) 168.52 ± 43.21 161.17 ± 31.80
HDL-C (mg/dL) 38.24 ± 9.99 43.37 ± 13.18∗
LDL-C (mg/dL) 107.97 ± 39.49 95.94 ± 29.34∗∗
Tg/HDL-C 3.26 ± 1.81 2.77 ± 1.46∗
CRP (mg/dL) 0.24 ± 0.57 0.14 ± 0.13
aCalculated in 15 femalesand 21 males. ∗P<. 05; ∗∗P<. 005; ∗∗∗P<. 0001.
Table 2: Laboratory and clinical variables before and after intervention of obese children according to gender.
Variables Female (n = 63) Male (n = 48)
Preintervention Postintervention Preintervention Postintervention
Height (cm) 148.46 ± 14.92 150.24 ± 13.62∗∗∗ 147.71 ± 14.95 149.96 ± 14.75∗∗∗
BMI (kg/m2) 27.64 ± 4.71 26.88 ± 4.71∗ 26.68 ± 2.85 26.12 ± 3.01∗
Z-score BMI 2.06 ± 0.37 1.87 ± 0.49∗∗∗ 2.11 ± 0.32 1.95 ± 0.40∗∗∗
Waist (cm) 85.89 ± 11.82 84.68 ± 12.19 85.21 ± 7.37 84.61 ± 7.17
Waist/Hip Ratio 0.87 ± 0.07 0.87 ± 0.06 0.92 ± 0.05†† 0.92 ± 0.05††
Fat Mass (mm2)a 2987.7 ± 1446.6 2362.0 ± 787.5∗ 2597.9 ± 628.2 2258.5 ± 578.5∗∗
Lean Mass (mm2)a 3977.2 ± 2052.0 4272.6 ± 1416.3 3954.5 ± 1515.5 4098.3 ± 1107.6
SBP (mm Hg) 107.39 ± 12.51 108.00 ± 11.52 105.79 ± 12.90 106.54 ± 11.44
DBP (mm Hg) 69.93 ± 9.87 68.93 ± 8.37 70.14 ± 8.89 68.33 ± 9.05
Fasting Glucose (mg/dL) 83.59 ± 9.87 83.43 ± 9.43 80.86 ± 14.69 84.83 ± 9.61
2 Hr pl Glucose (mg/dL) 100.04 ± 19.89 95.59 ± 16.31 91.81 ± 17.06† 94.12 ± 18.98
Fasting Insulin (mU/mL) 12.59 ± 8.50 9.29 ± 6.49∗∗ 9.53 ± 9.06† 8.97 ± 12.68∗
2 Hr pl Insulin (mU/mL) 71.72 ± 59.72 46.31 ± 29.26∗∗ 48.38 ± 50.79†† 39.08 ± 54.09††
HOMA 2.66 ± 1.73 1.93 ± 1.43∗∗ 1.93 ± 1.95†† 1.73 ± 2.14∗
QUICKI 0.34 ± 0.04 0.37 ± 0.04∗∗∗ 0.37 ± 0.05† 0.39 ± 0.05∗
Tg (mg/dL) 121.13 ± 66.00 104.00 ± 53.73 110.51 ± 57.15 121.76 ± 56.46
TC (mg/dL) 169.13 ± 42.53 160.60 ± 29.49 169.59 ± 47.09 158.93 ± 34.33
HDL-C (mg/dL) 40.06 ± 9.54 43.81 ± 9.03∗ 37.25 ± 9.37 41.69 ± 16.17
LDL-C (mg/dL) 105.49 ± 38.59 95.69 ± 25.54 113.49 ± 42.89 94.60 ± 31.99∗∗
Tg/HDL-C 3.17 ± 1.76 2.39 ± 1.30∗ 3.36 ± 2.09 3.20 ± 2.09
CRP (mg/dL) 0.46 ± 0.80 0.15 ± 0.16 0.32 ± 0.70 0.42 ± 0.96
aCalculated in 15 females and 21 males. †P<. 05, ††P<. 005 male preintervention versus female preintervention and male postintervention versus female
postintervention; ∗P<. 05, ∗∗P<. 005, ∗∗∗P<. 0001 postintervention versus preintervention.International Journal of Pediatric Endocrinology 5
Table 3: Laboratory and clinical variables before and after intervention in prepubertal and pubertal obese children.
Variables Prepuberty (n = 53) Puberty (n = 58)
Preintervention Postintervention Preintervention Postintervention
Height (cm) 137.87 ± 12.66 140.54 ± 12.13∗∗∗ 157.22 ± 10.10††† 158.61 ± 9.59∗∗∗†††
BMI (kg/m2) 25.62 ± 3.42 24.83 ± 3.63∗ 28.54 ± 3.96††† 28.02 ± 3.85∗†††
Z-score BMI 2.19 ± 0.31 1.98 ± 0.47∗∗∗ 1.96 ± 0.29††† 1.81 ± 0.37∗∗∗†
Waist (cm) 80.75 ± 9.12 80.02 ± 8.53 90.79 ± 8.43††† 89.70 ± 9.83†††
Waist/Hip Ratio 0.92 ± 0.07 0.92 ± 0.07 0.87 ± 0.06†† 0.87 ± 0.07†††
Fat Mass (mm2)a 2405.04 ± 753.91 2166.00 ± 624.89∗ 3684.20 ± 1178.32†† 2654.30 ± 665.60∗∗†
Lean Mass (mm2)a 3411.23 ± 1181.41 3706.65 ± 851.76 5401.10 ± 2144.89† 5378.30 ± 1272.13††
SBP (mm Hg) 101.59 ± 12.88 104.37 ± 11.96 111.00 ± 10.22†† 109.98 ± 10.48††
DBP (mm Hg) 69.79 ± 10.63 68.79 ± 9.19 70.49 ± 7.99 68.45 ± 8.36
Fasting Glucose (mg/dL) 81.61 ± 9.51 84.09 ± 8.89 83.16 ± 14.41 84.14 ± 14.41
2 Hr pl Glucose (mg/dL) 92.35 ± 13.34 97.68 ± 16.78 100.19 ± 22.45† 92.41 ± 17.97∗
Fasting Insulin (mU/mL) 9.28 ± 8.74 6.17 ± 5.97∗ 13.06 ± 8.73† 12.25 ± 11.49††
2 Hr pl Insulin (mU/mL) 55.95 ± 66.09 31.57 ± 32.40∗ 62.23 ± 47.19† 55.28 ± 47.03††
HOMA 1.85 ± 1.71 1.31 ± 1.38∗∗ 2.77 ± 1.91†† 2.43 ± 1.91†††
QUICKI 0.37 ± 0.05 0.40 ± 0.05∗∗∗ 0.34 ± 0.03††† 0.35 ± 0.04∗†††
Tg (mg/dL) 115.20 ± 65.65 111.85 ± 59.16 118.24 ± 59.14 112.38 ± 51.76
TC (mg/dL) 171.41 ± 40.49 161.66 ± 31.25 167.40 ± 48.63 158.61 ± 32.19
HDL-C (mg/dL) 38.85 ± 9.19 42.75 ± 12.38 38.70 ± 10.06 43.18 ± 13.22
LDL-C (mg/dL) 113.15 ± 34.78 96.48 ± 26.02∗ 105.21 ± 45.78 94.10 ± 31.43
Tg/HDL-C 3.12 ± 1.82 2.73 ± 1.62 3.41 ± 2.01 2.78 ± 1.53
CRP (mg/dL) 0.28 ± 0.68 0.13 ± 0.13 0.53 ± 0.82 0.55 ± 1.11
aCalculated in 26 Prepubertal and 10 Pubertal children. †P<. 05, ††P<. 005, †††P<. 0001 puberty preintervention versus prepuberty preintervention and
puberty postintervention versus prepuberty postintervention; ∗P<. 05, ∗∗P<. 005, ∗∗∗P<. 0001 postintervention versus preintervention.
Table 4: Laboratory and clinical variables of group A (Lost Weight) and B (Gained Weight) children before and after intervention.
Variables Group A (n = 72) Group B (n = 39)
Preintervention Postintervention Preintervention Postintervention
BMI (kg/m2) 27.91 ± 3.57 26.32 ± 3.87∗∗∗ 25.96 ± 4.52† 26.97 ± 4.40∗∗∗
Z-score BMI 2.10 ± 0.36 1.82 ± 0.49∗∗∗ 2.05 ± 0.32 2.05 ± 0.35†
Waist (cm) 87.39 ± 9.00 84.75 ± 9.37∗∗∗ 82.18 ± 11.48† 85.08 ± 11.94∗∗
Waist/Hip Ratio 0.89 ± 0.07 0.88 ± 0.06 0.89 ± 0.07 0.91 ± 0.05
Fat Mass (mm2)a 2915.41 ± 1326.75 2248.76 ± 727.70∗∗ 2621.63 ± 729.70 2348.94 ± 619.52∗
Lean Mass (mm2)a 4126.06 ± 2221.60 4194.76 ± 1346.42 3818.95 ± 1180.42 4149.73 ± 1151.34
SBP (mm Hg) 111.02 ± 11.23 105.15 ± 10.51∗∗ 99.08 ± 11.11†† 109.19 ± 11.85∗∗
DBP (mm Hg) 70.57 ± 9.97 66.86 ± 7.15∗ 70.65 ± 7.71 71.12 ± 9.57†
Fasting Glucose (mg/dL) 82.35 ± 9.49 83.98 ± 10.68 82.30 ± 8.90 83.54 ± 8.01
2 Hr pl Glucose (mg/dL) 96.31 ± 19.51 92.19 ± 18.05 96.13 ± 15.03 97.29 ± 15.11
Fasting Insulin (mU/mL) 11.02 ± 6.78 7.48 ± 5.55∗∗ 10.29 ± 10.85 9.36 ± 14.25∗
2 Hr pl Insulin (mU/mL) 55.04 ± 49.87 34.23 ± 26.73∗∗ 56.24 ± 59.64 49.93 ± 59.89
HOMA 2.27 ± 1.44 1.57 ± 1.28∗∗ 2.15 ± 2.31 1.75 ± 2.34∗
QUICKI 0.35 ± 0.04 0.38 ± 0.04∗∗ 0.37 ± 0.05 0.39 ± 0.05∗∗
Tg (mg/dL) 118.81 ± 55.78 105.30 ± 49.15 121.22 ± 80.07 128.75 ± 61.08
TC (mg/dL) 169.27 ± 46.08 158.22 ± 29.39 167.32 ± 38.94 165.92 ± 35.37
HDL-C (mg/dL) 38.75 ± 10.03 44.36 ± 13.19∗ 37.47 ± 10.07 41.84 ± 13.28
LDL-C (mg/dL) 109.82 ± 43.26 95.57 ± 29.24∗ 105.13 ± 33.47 96.50 ± 30.05
Tg/HDL-C 3.23 ± 1.53 2.51 ± 1.28∗ 3.31 ± 2.20 3.16 ± 1.65†
CRP (mg/dL) 0.18 ± 0.20 0.10 ± 0.08 0.31 ± 0.80 0.17 ± 0.16
aCalculatedin 17 group A and 19 group B children. †P<. 05, ††P<. 002 group B versus group A preintervention and postintervention. ∗P<. 05, ∗∗P<. 005,
∗∗∗P<. 0001 postintervention versus preintervention.6 International Journal of Pediatric Endocrinology
Table 5: Anthropometric variables, calories, nutrients, steps taken per day, exercise in hours per week and hours per day spent watching TV
and video games by obese children classiﬁed by their change in weight (n = 36).
Variables Lost Weight (Group A) (n = 16) Gained Weight (Group B) (n = 20)
Preintervention Postintervention Preintervention Postintervention
BMI (kg/m2) 27,47 ± 25,05 25,04 ± 3,88∗∗ 27.02 ± 4.60 27.39 ± 4.97
Z-score BMI 2,12 ± 0,28 1,73 ± 0,52∗ 2.15 ± 0.28 2.14 ± 0.32†
Exercise (hs/wk) 2.37 ± 2.55 5.33 ± 3.89∗ 2.48 ± 2.48 5.10 ± 3.57∗
Steps by Day 10070,00 ± 2931.65 23602.44 ± 4929.79∗∗ 9646.00 ± 2971.17 20507.33 ± 4193.69∗∗
TV-Video (hs/day) 4.69 ± 2.98 4.05 ± 1.96 4.16 ± 1.93 4.29 ± 2.35
†P<. 01 group B versus group A preintervention and postintervention. ∗P<. 005, ∗∗P<. 0001 postintervention versus preintervention.
3.3. Group B. Patients who gained weight had a further
increase in BMI (P<. 0001), waist circumference (P<. 005),
SBP (P<. 005), and in QUICKI (P<. 005) during the
8-month intervention period. Fat mass (P<. 05), fasting
insulin (P<. 05), and HOMA (P<. 05) decreased. Lean
mass, DBP, lipid concentrations, fasting and postprandial
glucose, postprandial insulin, and CRP remained stable
during the study period. HDL-C levels were low at baseline
and did not change during this period. Results of group B
can be seen in Table 4.
When we compared group A with group B we noticed
that,beforeintervention,BMI(P<. 05),waist circumference
(P<. 05), and systolic BP (P<. 002) were signiﬁcantly lower
in group B (Table 4). After intervention, BMI Z-score (P<
.05), diastolic BP (P<. 05), and the Tg/HDL-C ratio (P<
.05) were signiﬁcantly higher in group B.
In order to determine whether gender and pubertal
development had a signiﬁcant inﬂuence over the weight
change during intervention, we performed a logistic regres-
sionanalysis with weightgain orlossasadependentvariable.
It demonstrated that the inﬂuence of gender (P = .099) and
pubertal development (P = .157) was not signiﬁcant.
3.4. Subgroup. In a subgroup of 36 patients, 16 who either
maintained their weight or had a modest weight loss and
20 who gained weight, we analyzed the number of steps
taken per day counted with a pedometer and the number of
exercise hours per week. Patients in the former group lost
weight and decreased their BMI, while children in the latter
group increased their weight and BMI remained stable. The
number of steps taken per day and the amount of exercise
hours increased (P<. 0001 and P<. 005, resp.) in both
subgroups (Table 5). The number of hours spent watching
TV or playing video games showed a tendency to decrease in
patients who lost weight and of increasing in patients who
gained weight. When we compared subgroups, we noticed
that after intervention, BMI Z-score was signiﬁcantly higher
in patients who lost weight (P<. 01).
4.Discussion
Reports evaluating the eﬀect of exercise on body fat have
beencontradictory,withsomestudiesshowing anincrease in
body fat but not in visceral fat, others demonstrating stable
body composition, and yet others presenting a decrease in
fat mass and an increase in lean body mass [17, 27, 28]. In
our study, group A patients demonstrated an improvement
in anthropometric parameters with a decrease in BMI, Z-
score BMI, and waist circumference following moderate
physical activity and diet-based lifestyle-only intervention.
Additionally, in a subgroup of these patients, fat mass
decreased signiﬁcantly, and muscle mass remained stable
following intervention. It is interesting to note how fat mass
also decreased signiﬁcantly in a number of group B patients,
despite their weight increase. This suggests an important
role for exercise in improving body composition, even in the
absenceofweightloss,asinthisgroupofchildrenanincrease
of physical activity as measured by the number of hours of
exercise per week and by the number of steps taken was also
noticed.
A proinﬂammatory state with an increase in CRP levels
hasbeendetectedinobesechildrenandisoftenaccompanied
by alterations in endothelial function and arterial structure
[9, 14, 18, 29]. Studies of the eﬀect of physical activity or
lifestyle changes on inﬂammatory markers in children have
shown mixed results. Whereas some report no eﬀect on
hemostatic or inﬂammatory markers following exercise or
lifestyle-only intervention, others document a decrease in
circulatingﬁbrinogenconcentrations[30–32]orasigniﬁcant
decrease in previously elevated levelsof CRP, ﬁbrinogen, and
IL-6 [18]. In our study, a tendencytowards a decrease in CRP
levels following lifestyle-only intervention was found in all
patientgroups,buttheselevelsremained inthenormal range
both before and after intervention.
Recent studies have demonstrated the existence of a
link between weight reduction in overweight children and
improved insulin sensitivity following exercise or diet-based
lifestyle-only intervention [16, 33]. In our study, fasting
insulin levels and postprandial insulin levels decreased
following intervention, while indexes of insulin resistance
improved. These changes occurred even in the absence of
weightlossorfollowingonlymodestweightreduction.These
ﬁndings are in agreement with recent reports in which
short-term exercise-training programs were able to increase
insulin sensitivity and cardiorespiratory ﬁtness in obese
children, even in the absence of weight loss and without
measurable changes in body composition [17, 18]. How-
ever, whereas prepubertal children showed improvements
in insulin resistance, children undergoing puberty did not.
In the latter group, levels of fasting insulin, postprandialInternational Journal of Pediatric Endocrinology 7
insulin, and HOMA were higher, and QUICKI values were
lower. Compared to male patients, female patients were
found to have lower QUICKI values and higher levels
of fasting insulin, postprandial insulin, and HOMA. After
intervention, both females and males had increased QUICKI
values and lower levels of fasting insulin and HOMA. These
ﬁndings demonstrate how insulin sensitivity can be diﬀerent
during the various stages of adolescence and between sexes.
In our intervention study, concentrations of LDL choles-
terol and the Tg/HDL-C ratio decreased, and HDL concen-
trations increased, both in the whole group and in group
A children. Lipids remained stable in children who gained
weight. Barter et al. [34]d e m o n s t r a t e dh o w ,i na no b e s e
group of adult patients, an increase in Tg and a decrease
in HDL-C allowed for the identiﬁcation of patients with
generalized metabolic disorders. Similarly, in a recent study
[4]wefoundthat69%ofourobesechildrenhadan elevation
of the Tg/HDL-C ratio that correlated with all markers
of obesity and in a linear regression analysis proved to
b e ,t o g e t h e rw i t hB M I ,t h em a i nv a r i a b l ee x p l a i n i n gt h e
metabolic syndrome.
We evaluated children of both sexes and included among
them some that were in an age range in which puberty
inﬂuences insulin resistance. Ideally, this study should have
beenperformed separatelyinmalesandfemalesusingtighter
age ranges. However, we did analyze our data according to
gender (males versus females) and pubertal status (children
in Tanner stages 1-2 versus children in Tanner stages 3–
5). Another potential limitation of this study is the use
of HOMA and QUICKI as measures of insulin resistance,
instead of using the hyperinsulinemic-euglycemic clamp or
the frequently sampled iv glucose tolerance test, which are
considered to be more accurate. However, both HOMA and
QUICKI have been validated as surrogate markers of insulin
resistance in nondiabetic children and adolescents and
compare quite well to the more sophisticated tests of insulin
resistance [35, 36]. This study would have been strengthened
bytheuseofacontrolgroupofnondietingandnonexercising
obese children; however, it would have been very diﬃcult
and probably unethical for us to follow a subgroup of obese
children without any form of intervention, considering that
they sought our advise to lose excess weight and reduce
accompanying comorbidities.
In conclusion, a simple lifestyle-only intervention pro-
gram, leading to either limited weight loss or no weight
gain, helped redistribute body fat, decrease lipid levels, and
improve parameters of insulin sensitivity in overweight and
obese children. The reversibility of these auxological and
metabolic abnormalities following moderate lifestyle-only
intervention, even in the presence of very limited weight
loss or simply no weight gain, has important implica-
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